$TKMR Recent News End of QE turns institutions
Post# of 72745
Posted On: 09/29/2014 11:39:47 AM
$TKMR Recent News
End of QE turns institutions into sellers 3:20 p.m. Sept. 23, 2014 - The Trading Deck
Charting the bull-bear debate 11:51 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the bull-bear debate 11:33 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the next technical target: Dow 17,750 11:20 a.m. Sept. 18, 2014 - Michael Ashbaugh
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios 7:00 a.m. Sept. 26, 2014 - TheStreet.com
Want to Invest in Biotech Stocks? Learn the Rules First. 8:20 a.m. Sept. 25, 2014 - InvestorPlace.com
Tekmira Pharmaceuticals Corporation Shares End Summer On Wild Ride 12:52 p.m. Sept. 24, 2014 - benzinga.com
'Fast Money' Recap: How to Play the Falling Market 5:00 a.m. Sept. 24, 2014 - TheStreet.com
Ebola drug trials to be fast tracked in Africa 7:25 a.m. Sept. 23, 2014 - Seeking Alpha
Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor 7:48 p.m. Sept. 22, 2014 - TheStreet.com
Tekmira Pharmaceuticals' Ebola Run-Up Isn't In Touch With Reality 6:20 p.m. Sept. 22, 2014 - Seeking Alpha
Update: Tekmira Pharmaceuticals Corp. Has A Framework To Treat Ebola Patients 1:51 p.m. Sept. 22, 2014 - Seeking Alpha
Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today 12:02 p.m. Sept. 22, 2014 - TheStreet.com
FDA authorizes Tekmira to provide TKM-Ebola 11:20 a.m. Sept. 22, 2014 - Seeking Alpha
Tekmira Establishes Regulatory Framework For Emergency Use Of TKM-Ebola 8:15 a.m. Sept. 22, 2014 - benzinga.com
Who Is Working on Ebola? 9:59 a.m. Sept. 19, 2014 - Barrons.com
Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment 3:08 p.m. Sept. 18, 2014 - Seeking Alpha
Tekmira: Much More Than An Ebola Treatment 7:57 p.m. Sept. 14, 2014 - Seeking Alpha
Ebola: Desperate Days Ahead 3:14 p.m. Sept. 11, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
4 Companies To Look At After WHO Ebola Consultation In Geneva 11:51 a.m. Sept. 8, 2014 - Seeking Alpha
Cramer's Lightning Round - We Are Bottom Fishing In Ensco (9/5/14) 4:45 a.m. Sept. 7, 2014 - Seeking Alpha
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
End of QE turns institutions into sellers 3:20 p.m. Sept. 23, 2014 - The Trading Deck
Charting the bull-bear debate 11:51 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the bull-bear debate 11:33 a.m. Sept. 23, 2014 - Michael Ashbaugh
Charting the next technical target: Dow 17,750 11:20 a.m. Sept. 18, 2014 - Michael Ashbaugh
Use caution when investing in Ebola-related stocks 12:26 p.m. Aug. 28, 2014 - The Trading Deck
Newscast: Stocks finish the week with a flourish 6:29 p.m. Aug. 8, 2014 - MarketWatch
Monster Beverage jumps; Zynga sinks on results 4:37 p.m. Aug. 8, 2014 - Sue Chang
Dow gain biggest in over 4 months 4:09 p.m. Aug. 8, 2014 - Anora Mahmudova
Ebola drug maker's shares soar as FDA opens door to treatment use 12:20 p.m. Aug. 8, 2014 - Russ Britt
Tekmira moves closer to approval on Ebola drug 10:27 a.m. Aug. 8, 2014 - Russ Britt
Jobs pop, Dan Loeb's wisdom, Apple's iPad woes 9:01 a.m. May 2, 2014 - Shawn Langlois
Wednesday’s biggest gaining and declining stocks 4:32 p.m. Oct. 3, 2012 - MarketWatch
Tekmira Pharmaceuticals up 10% in premarket 9:00 a.m. July 18, 2012 - Steve Gelsi
Biotech Stock Mailbag: ProQR, Vertex Pharma, Tekmira, Agios 7:00 a.m. Sept. 26, 2014 - TheStreet.com
Want to Invest in Biotech Stocks? Learn the Rules First. 8:20 a.m. Sept. 25, 2014 - InvestorPlace.com
Tekmira Pharmaceuticals Corporation Shares End Summer On Wild Ride 12:52 p.m. Sept. 24, 2014 - benzinga.com
'Fast Money' Recap: How to Play the Falling Market 5:00 a.m. Sept. 24, 2014 - TheStreet.com
Ebola drug trials to be fast tracked in Africa 7:25 a.m. Sept. 23, 2014 - Seeking Alpha
Tekmira Experimental Ebola Drug Used to Treat Stricken U.S. Doctor 7:48 p.m. Sept. 22, 2014 - TheStreet.com
Tekmira Pharmaceuticals' Ebola Run-Up Isn't In Touch With Reality 6:20 p.m. Sept. 22, 2014 - Seeking Alpha
Update: Tekmira Pharmaceuticals Corp. Has A Framework To Treat Ebola Patients 1:51 p.m. Sept. 22, 2014 - Seeking Alpha
Why Tekmira Pharmaceuticals (TKMR) Stock Is Spiking Today 12:02 p.m. Sept. 22, 2014 - TheStreet.com
FDA authorizes Tekmira to provide TKM-Ebola 11:20 a.m. Sept. 22, 2014 - Seeking Alpha
Tekmira Establishes Regulatory Framework For Emergency Use Of TKM-Ebola 8:15 a.m. Sept. 22, 2014 - benzinga.com
Who Is Working on Ebola? 9:59 a.m. Sept. 19, 2014 - Barrons.com
Roadmap Capital's Hugh Cleland And Stephen Ireland: Due Diligence Rules In Biotech Investment 3:08 p.m. Sept. 18, 2014 - Seeking Alpha
Tekmira: Much More Than An Ebola Treatment 7:57 p.m. Sept. 14, 2014 - Seeking Alpha
Ebola: Desperate Days Ahead 3:14 p.m. Sept. 11, 2014 - Seeking Alpha
Ebola-Stricken Doc Receives Experimental Drug, But Which One? 2:20 p.m. Sept. 11, 2014 - TheStreet.com
Trade Ebola Stocks? Sure, But Don't Bet on Big Business Opportunity 9:36 a.m. Sept. 10, 2014 - TheStreet.com
WHO says Liberia may get overwhelmed by Ebola 7:20 a.m. Sept. 9, 2014 - Seeking Alpha
4 Companies To Look At After WHO Ebola Consultation In Geneva 11:51 a.m. Sept. 8, 2014 - Seeking Alpha
Cramer's Lightning Round - We Are Bottom Fishing In Ensco (9/5/14) 4:45 a.m. Sept. 7, 2014 - Seeking Alpha
Regulatory Approvals, Senior Notes Redemption, and Technical Updates - Research Reports on Tekmira, Regeneron, Valeant, Teva and United Therapeutics 9:20 a.m. Sept. 25, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 10:37 a.m. Sept. 24, 2014 - PR Newswire - PRF
Critical Alerts For Tekmira Pharmaceuticals, Herbalife, Alcoa, Actavis and Twitter Released By InvestorsObserver 9:39 a.m. Sept. 24, 2014 - PR Newswire - PRF
Tekmira Joins International Consortium to Conduct Clinical Trials of Ebola Virus Therapeutics in West Africa 6:11 a.m. Sept. 23, 2014 - GlobeNewswire
Tekmira Establishes Regulatory Framework for Emergency Use of TKM-Ebola 9:15 a.m. Sept. 22, 2014 - GlobeNewswire
Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Sept. 4, 2014 - PR Newswire - PRF
Upcoming Event, Positive Findings, Regulatory Approvals, and Vaccine License - Research Reports on WellPoint, Tekmira, Zoetis, Sanofi and GSK 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Tekmira's Lipid Nanoparticle (LNP) Technology Targeting Marburg Virus Highlighted in Scientific Publication 2:00 p.m. Aug. 20, 2014 - GlobeNewswire
Drug Approvals & Updates, Licensing Agreements, and Upcoming Conferences - Research Reports on Tekmira, MannKind, Eli Lilly, GSK and Cigna 8:30 a.m. Aug. 14, 2014 - PR Newswire - PRF
Tekmira Provides Corporate Update and Announces Second Quarter 2014 Results 4:31 p.m. Aug. 13, 2014 - GlobeNewswire
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Tekmira Conference Call and Webcast Advisory: Corporate Update and Second Quarter Financial Results 8:37 p.m. Aug. 7, 2014 - GlobeNewswire
FDA Modifies Tekmira's TKM-Ebola Clinical Hold to Partial Hold 4:47 p.m. Aug. 7, 2014 - GlobeNewswire
Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 12:20 p.m. July 21, 2014 - GlobeNewswire
Tekmira Receives $1.5 Million Milestone Payment 7:01 p.m. July 9, 2014 - GlobeNewswire
Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 3:15 a.m. July 3, 2014 - GlobeNewswire
Tekmira Initiating Phase I/II Clinical Trial in Patients with Hepatocellular Carcinoma 9:11 a.m. May 27, 2014 - GlobeNewswire
Tekmira Provides Corporate Update and Announces First Quarter 2014 Results 4:27 p.m. May 14, 2014 - GlobeNewswire
Tekmira Conference Call and Webcast Advisory: Corporate Update and First Quarter Financial Results 6:46 p.m. May 7, 2014 - GlobeNewswire
Tekmira's Partner Presents New Clinical Data for LNP-Enabled Patisiran (ALN-TTR02) 6:31 p.m. April 28, 2014 - GlobeNewswire
(0)
(0)